“Scleroderma is the epitome of complex autoimmune rheumatic disorders because it can affect any organ in the body. Scleroderma is a chronic illness that can place an incredible burden on patients and their families for a long period of time,” said Francesco Boin, MD, the chair of Rheumatology and director of the Scleroderma Program in the Kao Autoimmunity Institute at Cedars-Sinai. Research That Benefits PatientsCutting edge research is the best care we can offer scleroderma patients, said Boin, and leading that effort at Cedars-Sinai is Nunzio Bottini, MD, PhD, the director of the Kao Autoimmunity Institute. Then we test the hypotheses and based on the results of the experiments, develop therapies tailored to patients with scleroderma. At the Kao Autoimmunity Institute, we want to bring top investigators and clinicians together and leverage the culture of scientific excellence and collaboration here.

Source: CNN June 27, 2023 13:54 UTC